Evaluating the Efficacy and Stability of Expired Ciprofloxacin: A Comprehensive Assessment
Keywords:
Ciprofloxacin, Antibiotics, Drug Efficacy, Drug Stability, Pharmaceutical QualityAbstract
Medications that have exceeded their shelf life may degrade, become ineffective, or potentially harmful. Drug manufacturers and certain health organizations generally recommend discarding medications once the expiration date on the packaging has passed. However, it is important to note that the expiration date does not always definitively indicate that a drug has spoiled. The expiration date of antibiotics is significant as by this date the customer ensures the drug is effective, stable and safe. After this date, the active ingredient may destroy, leading to reduction in effectiveness and failure to treat infections, which can be reason for antibiotic resistance. This study aims to compare the antimicrobial activity of expired ciprofloxacin as example for antibiotics against standard bacterial strains with that of non-expired ciprofloxacin, Findings from this study could inform guidelines on the safe use of expired antibiotics. The study used several bacterial strains (Staphylococcus aureus, Escherichia coli, Salmonella and Shigella Flexenari ) and the consistency in results across all strains supports the conclusion that expired Ciprofloxacin may still be effective. The study did not evaluate the long-term degradation kinetics of Ciprofloxacin only a single time point (expired and non-expired) was compared. In addition, a larger sample size and multiple batches of expired Ciprofloxacin would improve reliability. Further laboratory research was needed to evaluate the effectiveness of expired antibiotics, especially in countries facing medication shortages or during emergencies and patients should avoid using expired antibiotics without professional consultation, even if they appear to be effective, to reduce the risk of reduced potency or bacterial resistance. In addition, Provide clear regulatory guidance from health authorities (e.g., Ministries of Health or Food and Drug Administrations) on the safe use of certain expired medications when necessary.
Downloads
References
American Medical Association, Council on Scientific Affairs. (2001). Pharmaceutical expiration dates (Report No. 1 of the Council on Scientific Affairs, A-01). https://www.ama-assn.org
Anderson, G., & Scott, M. (1991). Determination of product shelf life and activation energy for five drugs of abuse. Clinical Chemistry, 37, 398–402.
Bajaj, S., Singla, D., & Sakhuja, N. (2012). Stability testing of pharmaceutical products. Journal of Applied Pharmaceutical Science, 2(3), 129–138.
Blondeau, J. M. (1999). Expanded activity and utility of the new fluoroquinolones: A review. Clinical Therapeutics, 21(1), 3–15. https://doi.org/10.1016/S0149-2918(00)88274-9
Campoli-Richards, D. M., Monk, J. P., Price, A., Benfield, P., Todd, P. A., & Ward, A. (1988). Ciprofloxacin: A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs, 35(4), 373–447. https://doi.org/10.2165/00003495-198835040-00002
Cantrell, L., Suchard, J., Wu, A., & Gerona, R. (2012). Stability of active ingredients in long-expired prescription medications. Archives of Internal Medicine, 172(21), 1685–1687. https://doi.org/10.1001/archinternmed.2012.4382
Carstensen, J. T. (2000). Drug stability: Principles and practices (3rd ed.). Marcel Dekker.
Coker, T. J., & Dierfeldt, D. M. (2016). Acute bacterial prostatitis: Diagnosis and management. American Family Physician, 93(2), 114–120.
Cozzani, E., Chinazzo, C., Burlando, M., Romagnoli, M., & Parodi, A. (2016). Ciprofloxacin as a trigger for bullous pemphigoid: The second case in the literature. American Journal of Therapeutics, 23(5), e1202–e1204. https://doi.org/10.1097/MJT.0000000000000262
Davido, B., Michelon, H., Mamona, C., de Truchis, P., Jaffal, K., & Saleh-Mghir, A. (2024). Efficacy of expired antibiotics: A real debate in the context of repeated drug shortages. Antibiotics, 13(5), Article 466. https://doi.org/10.3390/antibiotics13050466
Dawson, M. (1994). Expiry dates. Australian Prescriber, 17(2), 46–48. https://doi.org/10.18773/austprescr.1994.051
Downey, P. J. (2015). Kinetics and salting-in of aspirin in aqueous acetic acid solutions: Shelf-life estimation. Journal of Pharmaceutical Sciences, 104(5), 1600–1607. https://doi.org/10.1002/jps.24374
Emmerson, A. M., & Jones, A. M. (2003). The quinolones: Decades of development and use. Journal of Antimicrobial Chemotherapy, 51(Suppl. 1), 1–10. https://doi.org/10.1093/jac/dkg208
Getahun, H., Belew, S., Hasen, G., Tefera, G., Mekasha, Y. T., & Suleman, S. (2024). Quality evaluation of selected expired fluoroquinolones medicines obtained from the public hospitals in Jimma zone, Oromia regional state, Ethiopia. Frontiers in Medicine, 11, Article 1420146. https://doi.org/10.3389/fmed.2024.1420146
Heras-Cañas, V., Gutiérrez-Soto, B., Almonte-Fernández, H., Lara-Oya, A., Navarro-Marí, J. M., Garrido-Frenich, A., Vázquez-Alonso, F., & Gutiérrez-Fernández, J. (2017). Antibiotic activity and concentrations in clinical samples from patients with chronic bacterial prostatitis. Actas Urológicas Españolas, 41(10), 635–641. https://doi.org/10.1016/j.acuro.2017.03.008
Khanchandani, R., Srivastava, B., Sinha, A., Gaur, S., Gaur, S., & Bharat, S. (2015). Efficacy, safety concern and disposal practices followed for expired drug preparations among medical personnel. International Journal of Current Research, 7(8), 19456–19461.
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010). How antibiotics kill bacteria: From targets to networks. Nature Reviews Microbiology, 8(6), 423–435. https://doi.org/10.1038/nrmicro2333
Kommanaboyina, B., & Rhodes, C. T. (1999). Trends in stability testing, with emphasis on stability during distribution and storage. Drug Development and Industrial Pharmacy, 25(7), 857–868. https://doi.org/10.1081/DDC-100102196
LeBel, M. (1988). Ciprofloxacin: Chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions. Pharmacotherapy, 8(1), 3–30. https://doi.org/10.1002/j.1875-9114.1988.tb03565.x
Lyon, R., Taylor, J., Porter, D., Prasanna, H., & Hussain, A. (2006). Stability profiles of drug products extended beyond labeled expiration dates. Journal of Pharmaceutical Sciences, 95(7), 1549–1560. https://doi.org/10.1002/jps.20636
McDonnell, N. J., & Jacob, E. (2015). Adverse effects of antibiotics and safety considerations in their use. Australian Prescriber, 38(3), 88–91. https://doi.org/10.18773/austprescr.2015.038
Mohamed, S., Elmohamady, M. N., Abdelrahman, S., Amer, M. M., & Abdelhamid, A. G. (2020). Antibacterial effects of antibiotics and cell-free preparations of probiotics against Staphylococcus aureus and Staphylococcus epidermidis associated with conjunctivitis. Saudi Pharmaceutical Journal, 28(12), 1755–1762. https://doi.org/10.1016/j.jsps.2020.10.012
Meyerhoff, A., Albrecht, R., Meyer, J. M., Dionne, P., Higgins, K., & Murphy, D. (2004). US Food and Drug Administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthrax. Clinical Infectious Diseases, 39(3), 303–308. https://doi.org/10.1086/421999
Owens, R. C., Jr., & Ambrose, P. G. (2005). Antimicrobial safety: Focus on fluoroquinolones. Clinical Infectious Diseases, 41(Suppl. 2), S144–S157. https://doi.org/10.1086/428051
Przyswa, E. (2013). Counterfeit medicines and criminal organisations. IRCAM.
Ramachandran, S. (2016). Drugs past their expiration date. Journal of the American Medical Association, 315(5), 510–511. https://doi.org/10.1001/jama.2015.19678
Regenthal, R., Stefanovic, D., Albert, T., Trauer, H., & Wolf, T. (2002). The pharmacologic stability of 35-year old theophylline. Human & Experimental Toxicology, 21(7), 343–346. https://doi.org/10.1191/0960327102ht267oa
Rehman, A., Patrick, W. M., & Lamont, I. L. (2019). Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: New approaches to an old problem. Journal of Medical Microbiology, 68(1), 1–10. https://doi.org/10.1099/jmm.0.000876
Richter, B., Bongaerts, B., & Metzendorf, M.-I. (2023). Thermal stability and storage of human insulin. Cochrane Database of Systematic Reviews, 2023(11), Article CD015385. https://doi.org/10.1002/14651858.CD015385
Rudolph, A., Dahmke, H., Kupferschmidt, H., Burden, A., & Weiler, S. (n.d.). Coadministration of tizanidine and ciprofloxacin: A retrospective analysis of the WHO pharmacovigilance database. European Journal of Clinical Pharmacology.
Šljivić Husejnović, M., Suljić, A., Taletović, A., Džambić, A., Ibišević, M., Smajlagić, A., Kozarević, E. C., Karić, E., & Haličević, A. (2025). [Title and journal information needed].
Smith, J. (2020). Pharmaceutical stability and efficacy. Journal of Pharmaceutical Sciences, 109(3), 123–130. https://doi.org/10.1016/j.xphs.2019.11.015
Tura, A., Dalecha, D., Yasir, M., Ketebo, T., & Noorulla, K. (2022). Expiry of medicine in public health facilities of Arsi Zone, Oromia Regional State, Ethiopia: A quantitative and qualitative study. Current Issues in Pharmacy and Medical Sciences, 35, 27–33. https://doi.org/10.2478/cipms-2022-0004
Unemo, M., Lahra, M. M., Cole, M., Galarza, P., Ndowa, F., Martin, I., Dillon, J. R., Ramon-Pardo, P., Bolan, G., & Wi, T. (2019). World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): Review of new data and evidence to inform international collaborative actions and research efforts. Sexual Health, 16(6), 517–529. https://doi.org/10.1071/SH19023
Ventola, C. L. (2015). The antibiotic resistance crisis: Part 1: Causes and threats. Pharmacy and Therapeutics, 40(4), 277–283.
Waksman, S. A. (1947). What is an antibiotic or an antibiotic substance? Mycologia, 39(5), 457–465. https://doi.org/10.1080/00275514.1947.12020685
Zhang, H. L., Tan, M., Qiu, A. M., Tao, Z., & Wang, C. H. (2017). Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: A network analysis. BMC Pulmonary Medicine, 17, Article 175. https://doi.org/10.1186/s12890-017-0517-0
Shlibak, A. A. A., & Dalla, L. O. F. B. (2020). The sustainable research long while between bee pollen and honey bee diversity in Libya: Literature review. International Journal of Social Sciences and Management Research, 7(1), 2545–5303.
Abdulla, S. A., Elshaari, F. A., Alshintari, M., & Zourgui, L. (2025). Phytochemical profiling and biological activity of the ethanolic extract of Phragmites australis. Open Veterinary Journal, 15(6), 2478. https://doi.org/10.5455/OVJ.2025.v15.i6.1
Benramadan, L., Abozid, A., & Alshintari, M. (2026). Comparative analysis of phenolic compounds in coffee prepared by American and Arabic brewing methods. Wadi Alshatti University Journal of Pure and Applied Sciences, 218–222.
Alapid, A., Alshintari, M., Alforjani, A., Albosefi, R., & Yahmid, M. (2025). Antioxidant activity of natural chamomile and commercial chamomile in Libya: A comparative study. Libyan Medical Journal, 205–209.
Alshintari, M. E., Bonner, P. L., & Hargreaves, A. J. (2023). Effect of dietary flavonoids on amine incorporation activity of transglutaminase 2 enzyme. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences, 3(1), 64–69. https://doi.org/10.5281/zenodo.7890123
Alshintari, M., Dhaw, E., & Alagnaf, M. (2025). Papillary thyroid cancer: Prevalence, diagnosis methods, symptoms and management options in Tripoli, Libya. AlQalam Journal of Medical and Applied Sciences, 340–344.
Alshintari, M., Salem, M. A., Mohamed, H., Elgheriani, M. R., Omran, H., Al-Jnaf, D., & Zidan, M. (2025). A comparative study of maceration and Soxhlet extraction for antibacterial activity of rosemary (Rosmarinus officinalis) leaves. [Journal information needed].
Abozid, A., Benramadan, L., & Alshintari, M. (2025). The influence of preparation methods on phenolic compounds content in green tea samples from the Libyan market. AlQalam Journal of Medical and Applied Sciences, 1072–1075.
Shlibak, A. A., Örgeç, M., & Zencirci, N. (2021). Wheat landraces versus resistance to biotic and abiotic stresses. In Wheat landraces (pp. 193–214). Springer International Publishing. https://doi.org/10.1007/978-3-030-67896-5_10
Shlıbak, A., & Zencirci, N. (2021). Wheat: Biotrophic fungi and resistance genes. Uluslararası Anadolu Ziraat Mühendisliği Bilimleri Dergisi, 3(1), 10–20.
Soliman, A., Mohamed, N., Almiar, F., & Shlibak, A. (2026). Effect of fenugreek (Trigonella foenum-graecum L.) extract on early growth parameters of Phaseolus vulgaris L. AlQalam Journal of Medical and Applied Sciences, 416–420.
Ben Dalla, L. O. F., Medeni, T. D., Medeni, I. T., & Ulubay, M. (2025). Enhancing healthcare efficiency at Almasara Hospital: Distributed data analysis and patient risk management. Economy: Strategy and Practice, 19(4), 54–72. https://doi.org/10.51176/1997-9967-2024-4-54-72
Dalla, L. O. F. B. (2020). Modeling by using Generic Modeling Environment (GME) domain-specific modeling language (DSL) for agile software development (ASD) types. [Publication information needed].
Alsharif, A., Ahmed, A. A., Musa, Z. A., Dalla, L. O. F. B., & Nouh, A. (2026). Drugs: The path of darkness between religious awareness and societal loss. International Journal of Academic Publishing in Educational Sciences and Humanities, 2(1), 49–56.
Alsharif, A., Solman, F. I., Gheidan, A. A. S., Ahmed, A. A., Dalla, L. O. F. B., Alsharif, M. A., & Imbayah, I. (2026). Photovoltaic cells: Principles of operation and performance characteristics. Journal of Scientific and Human Dimensions, 718–748. https://doi.org/10.65421/jshd.v2i1.122
Dalla, L. O. F. B. (2020). The influence of hospital management framework by the usage of electronic healthcare record to avoid risk management (Department of Communicable Diseases at Misurata Teaching Hospital: Case study). Electronic Healthcare Record Management, 20(4), 22–52. https://doi.org/10.51176/1954-9923-2020-4-22-52
